Alternative cancer treatment - TONY ISAACS OLEANDER PROTOCOL
ANVIRZEL® Clinical Trials and Research
STAGE IV / ADVANCED Cancer (NOT fast-growing)
Related to: TONY ISAACS OLEANDER PROTOCOL
The following excerpts are taken from the description of ANVIRZEL on the
Internet:
Anvirzel™ boosts immune system function,
inhibits tumor growth and promotes apoptosis of tumor cells
Extensive laboratory and
clinical experience indicate both cytotoxic and immunological activities for the
drug.
In developing a protocol for clinical trials, M.D. Anderson Cancer Center
states, "It is thought that the polysaccharides present in Oleander Extract are
capable of activating the immune cells, which in turn can recognize the epitopes
present on the cancer cell surfaces, thereby enhancing the efficacy of the
immune response. It is believed that the cytotoxic action present in the extract
may be essential for synergistic activities. It is believed that the cytotoxic
action both arrests tumor growth and prevents cancer cell reproduction as well
as having and/or producing a Tumor Necrosis Factorlike activity. Research has
proved conclusively that Oleander extract is active on dual pathways at the
cellular level to both inhibit the growth of tumor cells (through the
antiangiogenesis activity of the oleandrin) and to promote apoptosis of the
tumor cells.
Anvirzel™ effective
against several human malignant cell lines -
Extensive in vitro research has been conducted by Dr. Robert Newman, Chief of
Pharmacology, M.D. Anderson Cancer Center (MDACC), Houston, Texas. Dr. Newman
has tested Oleander Extract against a broad spectrum of human malignant cell
lines, and has demonstrated that Oleander Extract has a high order of efficacy.
Anvirzel™ stimulates immune system cells -
In addition to the research being conducted by M.D. Anderson Cancer Center,
concurrent research is being conducted by Dr. Wendell Winters, a noted
immunologist with the University of Texas Health Science Center in San
Antonio,Texas. Dr. Winter's work has confirmed that Oleander Extract has been
"shown to stimulate the immune system by stimulation of the function and
capability of specific subsets of mononuclear cells." In addition, Dr. Winters'
research has shown that Oleander Extract specifically stimulates T and B
lymphocytes, the cell-mediated and the humoral mediated immune systems.
Anvirzel™ drug approval begun in April 2000 -
a USFDA approved study entitled "Phase I Study of ANVIRZEL in Patients with
Advanced Solid Tumors" was commenced under the direction of Ronald Buckowski,
M.D. at Cleveland Clinic in Cleveland, Ohio.
Anvirzel™ indicated as therapy for cancer,
viral, autoimmune and inflammatory disease -
Because of its strong cytotoxic effect in combination with an equally strong
immunomodulatory effect, Oleander Extract is indicated as a therapy, both
primary and adjuvant, for cell proliferative disease (cancer), certain viral
disease, and autoimmune/inflammatory disease. Clinical application of Oleander
Extract in the United States, Ireland, and Honduras has demonstrated efficacy
against various neoplastic disease, hepatic disease such as Hepatitis C, late
and early stage HIV/AIDS, as well as autoimmune/inflammatory disease such as
rheumatoid arthritis and psoriasis. The results have been determined both by the
clinical practitioner and independent laboratory analysis using PET, CT scan,
MRI, and hematological screening.
At the very least, Anvirzel™ has improved
quality of life -
Using Oleander Extract Therapy, international clinicians have been treating
patients suffering from the above referenced disorders on a compassionate use
basis since 1997. Many of these patients were previously diagnosed as terminal.
These clinicians have experienced a very high level of success with disease
stabilization, partial remission, and complete remission, almost always
accompanied by a very marked improvement in the patients' quality of life.
Dr. Anibal Villatoro of Tegucigalpa, Honduras, Former Executive Director of the
Honduran Institute of Social Security (administrator of the public health
system) has since January of 1999 been conducting a compassionate use trial with
Oleander Extract for HIV (SIDA) patients in Tegucigalpa. His early results
indicate a strong level of response to Oleander Extract therapy with a feeling
of homeostasis (feeling of well being) and an improved quality of life, as well
as significant improvement in their immune systems. (Reports that slipped out
in late 1999 showed that Oleander Extract reversed AIDS, no matter what the
phase of the disease, arthritis, psoriasis, hepatitis C, and even diabetes in
some cases. Initially, Oleander Extract was thought to work only on cancers
found early, however, very positive results have been found in people given just
weeks to live. To top this all off, Oleander Extract seems to be the first
cancer remedy to show positive results for leiomyosarcoma, probably the
deadliest of cancers. Oleander extract also crosses the blood-brain barrier
(like Poly-MVA) and gives hope to people with brain tumors.)
The "Common Thread" running through almost all of the clinical records of the
patient population using Oleander Extract on a compassionate use basis has been
the marked improvement in the "quality of life" of those patients. This
includes, but is not limited to, homeostasis, marked improvement in pain
management with elimination of or marked reduction in use of analgesics,
positive response to antibiotics, increased appetite with concomitant weight
gain, and increase in energy with reduction of fatigue.
